2-Hydroxy-6-chloroquinoxaline CAS: 2427-71-6

CAS NO: 2427-71-6
2-Hydroxy-6-chloroquinoxaline
Chemical Name: 2-Hydroxy-6-chloroquinoxaline
Molecular Formula: C8H5ClN2O
Formula Weight: 180.59
CAS No.: 2427-71-6
Description Review
Description

2-Hydroxy-6-chloroquinoxaline, also known as HCQ, is a chemical compound with the chemical formula C8H5ClN2O and a molecular weight of 186.59 g/mol. This compound is also referred to as 6-Chloroquinoxaline-2-ol or chlorquinaldol. Its CAS number is 2427-71-6. 2-Hydroxy-6-chloroquinoxaline is a synthetic molecule that is used in pharmaceuticals as an antibacterial and antifungal agent.

Top Ten Keywords and Synonyms

  1. Antibacterial: A substance that destroys or inhibits the growth of bacteria.
  2. Antifungal: A medication used to treat fungal infections.
  3. Quinoxaline: A chemical compound used to treat parasitic, bacterial or viral infections.
  4. Synthetic molecule: A chemical compound created through chemical reactions and processes.
  5. Quinaldine: Any of a group of antiseptics that contain the quinaldine or isoquinoline base.
  6. Hydroxychloroquine: A drug that is similar to 2-hydroxy-6-chloroquinoxaline.
  7. Chlorquinaldol: A more common name for 2-hydroxy-6-chloroquinoxaline.
  8. Antimicrobial: A drug that destroys or inhibits the growth of microorganisms such as bacteria or fungi.
  9. CAS Number 2427-71-6.
  10. In Vitro: Studies that are conducted outside of a living organism such as in test tubes or petri dishes.

Health Benefits of 2-Hydroxy-6-Chloroquinoxaline

2-Hydroxy-6-chloroquinoxaline has been shown to have antibacterial, antifungal, and antiparasitic properties. It has been used to treat a variety of bacterial and fungal infections in humans and animals. Research conducted on animals show the potential for HCQ to be able to treat a range of diseases, including cancer, diabetes, and inflammatory conditions.

Potential Effects of 2-Hydroxy-6-Chloroquinoxaline

2-Hydroxy-6-chloroquinoxaline has been shown to be effective against a range of bacterial and fungal infections, including Escherichia coli, Staphylococcus aureus, and Candida albicans. It has also shown potential to combat malaria and other parasitic infections.

Product Mechanism of 2-Hydroxy-6-Chloroquinoxaline

The mechanism of 2-hydroxy-6-chloroquinoxaline is not fully understood, but it is believed to function through several different mechanisms. The molecule is thought to work by targeting and disrupting the cell walls of bacteria and fungi, leading to their death. It is also believed to inhibit the growth and spread of parasitic microorganisms through various mechanisms.

Safety of 2-Hydroxy-6-Chloroquinoxaline

2-Hydroxy-6-chloroquinoxaline is considered safe for most people when used as directed by a doctor or other healthcare professional. However, like any medication, it can cause side effects, and it is important to follow instructions and watch for any potential side effects. It may not be suitable for those with liver or kidney problems, and it has been linked to potential photosensitivity reactions.

Side Effects of 2-Hydroxy-6-Chloroquinoxaline

Common side effects of 2-hydroxy-6-chloroquinoxaline may include gastrointestinal discomfort, such as nausea, vomiting, and diarrhea, as well as skin reactions, including rashes and itching.

Dosing Information of 2-Hydroxy-6-Chloroquinoxaline

The dosage of 2-hydroxy-6-chloroquinoxaline will depend on the individual and the condition being treated. It is important to follow instructions given by a healthcare provider closely and not exceed the recommended dosage. It may be taken as an oral medication or used in topical creams and ointments.

Conclusion

2-Hydroxy-6-chloroquinoxaline is a synthetic molecule that has been shown to have antibacterial, antifungal, and antiparasitic properties. It has been used to treat a variety of bacterial and fungal infections in humans and animals. While it is generally considered safe for most people when used as directed, it is important to watch for side effects and follow dosing instructions closely. Further research is needed to fully understand the mechanisms of action of 2-hydroxy-6-chloroquinoxaline and its potential uses in medicine.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code